HST Global (HSTC) 10-K 1 Apr 19 2018 FY Annual report Financial data

Document and Entity Information

Document and Entity Information	12 Months Ended
	Dec. 31, 2018USD ($)shares
Details
Registrant Name	HST GLOBAL, INC.
Registrant CIK	0000797564
SEC Form	10-K
Period End date	Dec. 31, 2018
Fiscal Year End	--12-31
Trading Symbol	HSTC
Tax Identification Number (TIN)	731215433
Number of common stock shares outstanding | shares	36,719,854
Public Float | $	$ 87,101
Filer Category	Non-accelerated Filer
Current with reporting	Yes
Voluntary filer	No
Well-known Seasoned Issuer	No
Shell Company	false
Small Business	true
Emerging Growth Company	false
Amendment Flag	false
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	FY
Entity File Number	000-15303
Entity Incorporation, State Country Name	Nevada
Entity Address, Address Line One	150 Research Drive
Entity Address, City or Town	Hampton
Entity Address, State or Province	VA
Entity Address, Postal Zip Code	23666
City Area Code	757
Local Phone Number	766-6100

Statement of Financial Position

Statement of Financial Position - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Current Assets
Cash and cash equivalents	$ 0	$ 291
Total Current Assets	0	291
Total Assets	0	291
LIABILITIES AND STOCKHOLDERS' DEFICIT
Total Liabilities	3,370,942	3,192,898
Stockholders' Deficit
Preferred stock; 5,000,000 shares authorized, at $0.001 par value, - 0- shares issued and outstanding, respectively	0	0
Common stock; 100,000,000 shares authorized, at $0.001 par value, 36,719,854 shares issued and outstanding, respectively	36,720	36,720
Additional paid-in capital	2,384,824	2,384,824
Accumulated deficit	(5,792,486)	(5,614,151)
Total Stockholders' Deficit	(3,370,942)	(3,192,607)
Current Liabilities
Bank Overdrafts	2,957	0
Accounts Payable and Accrued Liabilities, Current	3,228	4,688
Accounts payable and accrued expenses - related parties	505,959	505,959
Accrued officer compensation	1,110,000	990,000
Accrued related party interest	376,629	340,881
Notes payable - related party	1,372,169	1,351,369
Total Current Liabilities	3,370,942	3,192,898
Total Liabilities and Stockholders' Deficit	$ 0	$ 291

Statement of Financial Positi_2

Statement of Financial Position - Parenthetical - $ / shares	Dec. 31, 2018	Dec. 31, 2017
Details
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares, Issued	36,719,854	36,719,854
Common Stock, Shares, Outstanding	36,719,854	36,719,854

Income Statement

Income Statement - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Details
Revenues	$ 0	$ 0
Operating Expenses:
Consulting	120,000	120,000
General and administrative	22,587	32,995
Total Operating Expenses	142,587	152,995
Net Loss from Operations	(142,587)	(152,995)
Other Income (Expense)
Interest expense	(35,748)	(35,748)
Gain on forgiveness of accounts payable	0	23,651
Total Other Income (Expense)	(35,748)	(12,097)
Net loss	$ (178,335)	$ (165,092)
Loss Per Share: Basic and Diluted - Common	$ 0	$ 0
Weighted Average Shares Outstanding: Basic and Diluted - Common	36,719,854	36,719,854

Statement of Stockholders' Equi

Statement of Stockholders' Equity - USD ($)	Common Stock	Additional Paid-in Capital	Retained Earnings
Balance, December 31, 2016	$ 36,720	$ 2,384,824	$ (5,449,059)
Balance, December 31, 2016	36,719,854
Balance, December 31, 2016	$ 36,720	2,384,824	(5,449,059)
Balance, December 31, 2016	36,719,854
Net Loss	$ 0	0	(165,092)
Balance, December 31, 2017 at Dec. 31, 2016	$ 36,720	2,384,824	(5,449,059)
Balance, December 31, 2017 at Dec. 31, 2016	36,719,854
Balance, December 31, 2018 at Dec. 31, 2017	$ 36,720	2,384,824	(5,614,151)
Balance, December 31, 2018 at Dec. 31, 2017	36,719,854
Balance, December 31, 2016	$ 36,720	2,384,824	(5,614,151)
Balance, December 31, 2016	36,719,854
Balance, December 31, 2016	$ 36,720	2,384,824	(5,614,151)
Balance, December 31, 2016	36,719,854
Net Loss	$ 0	0	(178,335)
Balance, December 31, 2018 at Dec. 31, 2018	$ 36,720	2,384,824	(5,792,486)
Balance, December 31, 2018 at Dec. 31, 2018	36,719,854
Balance, December 31, 2016	$ 36,720	$ 2,384,824	$ (5,792,486)
Balance, December 31, 2016	36,719,854

Statement of Cash Flows

Statement of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash Flows from Operating Activities:
Net loss	$ (178,335)	$ (165,092)
Adjustments to reconcile net loss to net cash used in operating activities:
Gain on forgiveness of accounts payable	0	23,651
Changes in operating assets and liabilities:
Bank overdraft payable	(2,957)	0
Accounts payable and accrued expenses	(1,461)	(3,121)
Accrued officer compensation	120,000	120,000
Accrued related party interest	35,748	35,748
Net Cash used in Operating Activities	(21,091)	(29,874)
Cash Flows from Investing Activities:
Net Cash used in Investing Activities	0	0
Cash Flows from Financing Activities:
Proceeds from notes payable - related party	20,800	29,700
Net cash provided by financing activities	20,800	29,700
Net Decrease in cash	(291)	(174)
Cash at Beginning of Period	291	465
Cash at End of Period	0	291
Supplemental Disclosures of Cash Flow Information
Cash paid for interest	0	0
Cash paid for taxes	$ 0	$ 0

NOTE 1 - ORGANIZATION AND PRINC

NOTE 1 - ORGANIZATION AND PRINCIPAL ACTIVITIES	12 Months Ended
	Dec. 31, 2018
Notes
NOTE 1 - ORGANIZATION AND PRINCIPAL ACTIVITIES	NOTE 1 - ORGANIZATION AND PRINCIPAL ACTIVITIES HST Global, Inc. (“the Company”) was incorporated on April 11, 1984 under the laws of the State of Delaware under the name of NT Holding Corporation. The Company has made several acquisitions and disposals of various business entities and activities. On May 9, 2008, the Company entered into a Merger and share exchange agreement with Health Source Technologies, Inc. This business acquisition has been accounted for as a reverse merger or recapitalization of Health Source Technologies, Inc. At the time of the merger NT Holding Corporation had disposed of its assets and liabilities and had minimal operations. Immediately after the acquisition the Company changed its name to HST Global, Inc. Health Source Technologies, Inc. was incorporated under the laws of the State of Nevada on August 6, 2007. The Company is currently headquartered in Hampton, Virginia. HST Global, Inc. is an integrated Health and Wellness Biotechnology company that is developing and/or acquiring a network of Wellness Centers worldwide with the primary focus on homeopathic and alternative treatments of late stage cancer and other life threatening diseases. In addition, the Company intends to acquire innovative products for the treatment of life threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed significant clinical testing for the treatment of late stage cancer and/or life threatening diseases.

NOTE 2 - SIGNIFICANT ACCOUNTING

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2018
Notes
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-K. Principles of Consolidation The consolidated financial statements include our wholly-owned subsidiary. Intercompany balances and transactions have been eliminated. Accounting Method The Company’s financial statements are prepared using the accrual method of accounting. The Company has elected a December 31 year-end. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. Income Taxes The Company accounts for income taxes in accordance with accounting guidance now codified as FASB ASC 740, " Income Taxes The Company applies the provisions of ASC 740, “ Accounting for Uncertainty in Income Taxes Basic and Diluted Loss Per Share The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net income (loss) per share in accordance with ASC 260. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is antidilutive. The Company had no common stock equivalents outstanding as of December 31, 2018 and 2017. Stock-Based Compensation The Company adopted ASC 718, “Stock Compensation”, Fair Value of Financial Instruments ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under this standard certain assets and liabilities must be measured at fair value, and disclosures are required for items measured at fair value. The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows: Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. The fair value of the Company’s cash is based on quoted prices and therefore classified as Level 1. Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs). Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability. Recently Issued Accounting Pronouncements Management has considered all recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s consolidated financial statements.

NOTE 3 - GOING CONCERN

NOTE 3 - GOING CONCERN	12 Months Ended
	Dec. 31, 2018
Notes
NOTE 3 - GOING CONCERN	NOTE 3 – GOING CONCERN The Company’s consolidated financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business within one year after the date these financial statements were issued. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. There is substantial doubt that the Company can continue as a going concern for a period of one year from the issuance of these financial statements. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. Management’s plan to support the Company in its operations and to maintain its business strategy is to raise funds through public offerings and to rely on officers and directors to perform essential functions with minimal compensation. If the Company does not raise all of the money it needs from public offerings, it will have to find alternative sources, such as a second public offering, a private placement of securities, or loans from its officers, directors or others. If the Company requires additional cash and is unable to raise it, it will either have to suspend operations until the cash is raised, or cease business entirely. The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

NOTE 4 - ACCOUNTS PAYABLE AND A

NOTE 4 - ACCOUNTS PAYABLE AND ACCURED EXPENSES - RELATED PARTIES	12 Months Ended
	Dec. 31, 2018
Notes
NOTE 4 - ACCOUNTS PAYABLE AND ACCURED EXPENSES - RELATED PARTIES	NOTE 4 – ACCOUNTS PAYABLE AND ACCURED EXPENSES – RELATED PARTIES Accounts payable and accrued expenses - related parties consist of the following at December 31, 2018 and 2017: December 31, 2018 December 31, 2017 The Health Network, Inc. $ 365,462 $ 365,462 Ronald Howell 43,770 43,770 Eric Clemons 96,727 96,727 Total $ 505,959 $ 505,959

NOTE 5 - NOTES PAYABLE - RELATE

NOTE 5 - NOTES PAYABLE - RELATED PARTIES	12 Months Ended
	Dec. 31, 2018
Notes
NOTE 5 - NOTES PAYABLE - RELATED PARTIES	NOTE 5 – NOTES PAYABLE – RELATED PARTIES During the year ended December 31, 2018, the Company received $20,800 in additional cash loans from various related parties. During the year ended December 31, 2017, the Company received $29,700 in additional cash loans from various related parties. Total related party notes payable as of December 31, 2018 were $1,372,169. Of this total, $595,800 of related party notes payable is unsecured, bears interest at 6 percent per annum, and is due on demand. Also of this total, $200,000 is unsecured, bears a flat owed interest amount of $46,000, and is due on demand. The remaining $576,369 of related party notes payable is unsecured, bears no interest, and is due on demand. Included in the related party notes payable balance is a $50,000 penalty fee associated with one of its related party notes due to nonpayment.

NOTE 6 - RELATED PARTY TRANSACT

NOTE 6 - RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2018
Notes
NOTE 6 - RELATED PARTY TRANSACTIONS	NOTE 6 - RELATED PARTY TRANSACTIONS Executive Offices The Company's executive offices are located at 150 Research Dr., Hampton VA. These offices are leased by The Health Network, Inc. ("THN"), of which Ron Howell is President. THN allows the Company to use the office space without a formal sublease or rental agreement. At December 31, 2018 and 2017, the Company owes THN an amount of $365,462 and $365,462 respectively, for amounts due under this agreement from previous years. Consulting Agreements The Company has entered into a consulting agreement with Mr. Howell, President of the Company, whereby the Company agreed to pay Mr. Howell $10,000 per month for consulting services through December 31, 2010. Mr. Howell received 714,286 shares of common stock valued at $120,000 as a partial payment for amounts owed under this agreement. The consulting agreement may be terminated at will by the Company. The Company intends to continue to engage Mr. Howell as a consultant until his consulting services are no longer required. As of December 31, 2018 and 2017, the Company owes Mr. Howell $1,040,000 and $920,000, respectively under the agreement. The Company entered into a consulting agreement with Eric Clemons, a shareholder of the Company, whereby the Company agreed to pay Mr. Clemons $10,000 per month for consulting services through December 2009. This employment agreement carried the provision that it could be extended beyond this date upon mutual agreement by both parties and that the agreement could be canceled by the Company at any time after that date. The Company continued to accrue amounts owed under this agreement through July of 2010. The balance owed to Mr. Clemons at December 31, 2018 and December 31, 2017 is $70,000 and $70,000, respectively under this agreement. The Company disputes this amount and is currently assessing legal issues surrounding this obligation.

NOTE 7 - INCOME TAXES

NOTE 7 - INCOME TAXES	12 Months Ended
	Dec. 31, 2018
Notes
NOTE 7 - INCOME TAXES	NOTE 7 – INCOME TAXES The Company follows ASC 740, under which deferred income taxes reflect the net effect of (a) temporary difference between carrying amounts of assets and liabilities for financial purposes and the amounts used for income tax reporting purposes, and (b) net operating loss carry-forwards. No net provision for refundable Federal income tax has been made in the accompanying statement of loss because no recoverable taxes were paid previously. Similarly, no deferred tax asset attributable to the net operating loss carry-forward has been recognized, as it is not deemed likely to be realized. The cumulative tax effect at the expected rate of 21 percent (for 2018) and 34 percent (for 2017) of significant items comprising our net deferred tax amount is as follows: Year ended December 31, 2018 Year ended December 31, 2017 Income tax benefit attributable to: Net operating loss $ (37,450) $ (56,131) Change in valuation allowance 37,450 56,131 Net refundable amount $ - $ - The cumulative tax effect at the expected rate of 21 percent (for 2018) and 34 percent (for 2017) of significant items comprising our net deferred tax amount is as follows: December 31, 2018 December 31, 2017 Deferred tax asset attributable to: Net operating loss carry forwards $ (1,237,814) $ (1,934,445) Common stock issued for services 113,692 184,072 Valuation allowance 1,124,122 1,759,373 Net deferred tax asset $ - $ - The Company’s zero percent effective tax rate for each year, as compared to the 21 percent statutory rate, results from non-deductible stock based compensation and the change in valuation allowance. At December 31, 2018, the Company had an unused net operating loss carry-forward of approximately $1,237,814 that is available to offset future taxable income; the loss carry-forward will begin to expire in 2027.

NOTE 8 - SUBSEQUENT EVENTS

NOTE 8 - SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2018
Notes
NOTE 8 - SUBSEQUENT EVENTS	NOTE 8 – SUBSEQUENT EVENTS In accordance with ASC 855, Company management reviewed all material events through the date of this report and determined that there are no material subsequent events to report.

NOTE 2 - SIGNIFICANT ACCOUNTI_2

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Basis of Presentation (Policies)	12 Months Ended
	Dec. 31, 2018
Policies
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-K.

NOTE 2 - SIGNIFICANT ACCOUNTI_3

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Principles of Consolidation (Policies)	12 Months Ended
	Dec. 31, 2018
Policies
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include our wholly-owned subsidiary. Intercompany balances and transactions have been eliminated.

NOTE 2 - SIGNIFICANT ACCOUNTI_4

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Accounting Method (Policies)	12 Months Ended
	Dec. 31, 2018
Policies
Accounting Method	Accounting Method The Company’s financial statements are prepared using the accrual method of accounting. The Company has elected a December 31 year-end.

NOTE 2 - SIGNIFICANT ACCOUNTI_5

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Use of Estimates (Policies)	12 Months Ended
	Dec. 31, 2018
Policies
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

NOTE 2 - SIGNIFICANT ACCOUNTI_6

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Cash and Cash Equivalents (Policies)	12 Months Ended
	Dec. 31, 2018
Policies
Cash and Cash Equivalents	Cash and Cash Equivalents We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents.

NOTE 2 - SIGNIFICANT ACCOUNTI_7

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Income Taxes (Policies)	12 Months Ended
	Dec. 31, 2018
Policies
Income Taxes	Income Taxes The Company accounts for income taxes in accordance with accounting guidance now codified as FASB ASC 740, " Income Taxes The Company applies the provisions of ASC 740, “ Accounting for Uncertainty in Income Taxes

NOTE 2 - SIGNIFICANT ACCOUNTI_8

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Basic and Diluted Income (Loss) Per Share (Policies)	12 Months Ended
	Dec. 31, 2018
Policies
Basic and Diluted Income (Loss) Per Share	Basic and Diluted Loss Per Share The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net income (loss) per share in accordance with ASC 260. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is antidilutive. The Company had no common stock equivalents outstanding as of December 31, 2018 and 2017.

NOTE 2 - SIGNIFICANT ACCOUNTI_9

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Stock-Based Compensation (Policies)	12 Months Ended
	Dec. 31, 2018
Policies
Stock-Based Compensation	Stock-Based Compensation The Company adopted ASC 718, “Stock Compensation”,

NOTE 2 - SIGNIFICANT ACCOUNT_10

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Fair Value of Financial Instruments (Policies)	12 Months Ended
	Dec. 31, 2018
Policies
Fair Value of Financial Instruments	Fair Value of Financial Instruments ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under this standard certain assets and liabilities must be measured at fair value, and disclosures are required for items measured at fair value. The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows: Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. The fair value of the Company’s cash is based on quoted prices and therefore classified as Level 1. Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs). Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability.

NOTE 2 - SIGNIFICANT ACCOUNT_11

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Recently Issued Accounting Pronouncements (Policies)	12 Months Ended
	Dec. 31, 2018
Policies
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Management has considered all recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s consolidated financial statements.

NOTE 7 - INCOME TAXES_ Schedule

NOTE 7 - INCOME TAXES: Schedule of Components of Income Tax Expense (Benefit) (Tables)	12 Months Ended
	Dec. 31, 2018
Tables/Schedules
Schedule of Components of Income Tax Expense (Benefit)	The cumulative tax effect at the expected rate of 21 percent (for 2018) and 34 percent (for 2017) of significant items comprising our net deferred tax amount is as follows: Year ended December 31, 2018 Year ended December 31, 2017 Income tax benefit attributable to: Net operating loss $ (37,450) $ (56,131) Change in valuation allowance 37,450 56,131 Net refundable amount $ - $ -

NOTE 7 - INCOME TAXES_ Schedu_2

NOTE 7 - INCOME TAXES: Schedule of Deferred Tax Assets and Liabilities (Tables)	12 Months Ended
	Dec. 31, 2018
Tables/Schedules
Schedule of Deferred Tax Assets and Liabilities	The cumulative tax effect at the expected rate of 21 percent (for 2018) and 34 percent (for 2017) of significant items comprising our net deferred tax amount is as follows: December 31, 2018 December 31, 2017 Deferred tax asset attributable to: Net operating loss carry forwards $ (1,237,814) $ (1,934,445) Common stock issued for services 113,692 184,072 Valuation allowance 1,124,122 1,759,373 Net deferred tax asset $ - $ -

NOTE 5 - NOTES PAYABLE - RELA_2

NOTE 5 - NOTES PAYABLE - RELATED PARTIES (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Details
Proceeds from notes payable - related party	$ 20,800	$ 29,700
Notes payable - related party	$ 1,372,169	$ 1,351,369

NOTE 6 - RELATED PARTY TRANSA_2

NOTE 6 - RELATED PARTY TRANSACTIONS (Details)	Dec. 31, 2017	Dec. 31, 2018
THN Office Space.
Related Party Transaction, Description of Transaction	The Company's executive offices are located at 150 Research Dr., Hampton VA. These offices are leased by The Health Network, Inc. ("THN"), of which Ron Howell is President. THN allows the Company to use the office space without a formal sublease or rental agreement.
Related Party Transaction, Terms and Manner of Settlement	At December 31, 2018 and 2017, the Company owes THN an amount of $365,462 and $365,462 respectively, for amounts due under this agreement from previous years.
Howell Consulting Agreement
Related Party Transaction, Description of Transaction	The Company has entered into a consulting agreement with Mr. Howell, President of the Company, whereby the Company agreed to pay Mr. Howell $10,000 per month for consulting services through December 31, 2010.
Related Party Transaction, Terms and Manner of Settlement		Mr. Howell received 714,286 shares of common stock valued at $120,000 as a partial payment for amounts owed under this agreement. The consulting agreement may be terminated at will by the Company. The Company intends to continue to engage Mr. Howell as a consultant until his consulting services are no longer required. As of December 31, 2018 and 2017, the Company owes Mr. Howell $1,040,000 and $920,000, respectively under the agreement.
Clemons Consulting Agreement
Related Party Transaction, Description of Transaction		The Company entered into a consulting agreement with Eric Clemons, a shareholder of the Company, whereby the Company agreed to pay Mr. Clemons $10,000 per month for consulting services through December 2009.
Related Party Transaction, Terms and Manner of Settlement		This employment agreement carried the provision that it could be extended beyond this date upon mutual agreement by both parties and that the agreement could be canceled by the Company at any time after that date. The Company continued to accrue amounts owed under this agreement through July of 2010. The balance owed to Mr. Clemons at December 31, 2018 and December 31, 2017 is $70,000 and $70,000, respectively under this agreement. The Company disputes this amount and is currently assessing legal issues surrounding this obligation.

NOTE 7 - INCOME TAXES_ Schedu_3

NOTE 7 - INCOME TAXES: Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income tax benefit attributable to:
Net operating loss	$ (37,450)	$ (56,131)
Change in valuation allowance	37,450	56,131
Net refundable amount	$ 0	$ 0

NOTE 7 - INCOME TAXES_ Schedu_4

NOTE 7 - INCOME TAXES: Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Deferred tax asset attributable to:
Net operating loss carry forwards	$ (1,237,814)	$ (1,934,445)
Common stock issued for services	113,692	184,072
Valuation allowance	1,124,122	1,759,373
Net deferred tax asset	$ 0	$ 0